INmune Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.About INMB
INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer’s disease.
CEORaymond J. Tesi
CEORaymond J. Tesi
Employees10
Employees10
HeadquartersBoca Raton, Florida
HeadquartersBoca Raton, Florida
Founded2015
Founded2015
Employees10
Employees10
INMB Key Statistics
Market cap209.23M
Market cap209.23M
Price-Earnings ratio-7.69
Price-Earnings ratio-7.69
Dividend yield—
Dividend yield—
Average volume70.92K
Average volume70.92K
High today$12.05
High today$12.05
Low today$11.28
Low today$11.28
Open price$11.81
Open price$11.81
Volume96.50K
Volume96.50K
52 Week high$14.74
52 Week high$14.74
52 Week low$5.87
52 Week low$5.87
INMB News
Simply Wall St 6d
Individual investors invested in INmune Bio, Inc. up 10% last week, insiders too were rewarded - Simply Wall StKey Insights Significant control over INmune Bio by individual investors implies that the general public has more power to influence management and governance-...